Interim Buprenorphine vs. Waiting List for Opioid Dependence

Sigmon, Stacey C.; Ochalek, Taylor A.; Meyer, Andrew; Hruska, Bryce; Heil, Sarah H.; Badger, Gary J.; Rose, Gail L.; Brooklyn, John; Schwartz, Robert P.; Moore, Brent A.; Higgins, Stephen T.

doi:10.1056/nejmc1610047

Cited by 67 publications

(67 citation statements)

References 5 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Waitlist control participants remained on the waitlist of their local clinic and did not receive these services. The primary outcomes from this study demonstrated the efficacy of IBT and have been reported previously (Sigmon et al, 2016). As only IBT participants received the HIV + HCV education described below, our analyses focused on those individuals.…”

Section: Methodssupporting

confidence: 82%

A novel mHealth application for improving HIV and Hepatitis C knowledge in individuals with opioid use disorder: A pilot study

Ochalek

Heil

Higgins

et al. 2018

Drug and Alcohol Dependence

Self Cite

View full text Add to dashboard Cite

This HIV+Hepatitis Education intervention was associated with significant and sustained improvements in knowledge of HIV + HCV transmission and risk behaviors in this vulnerable group of individuals with OUD. Given the continuing opioid epidemic, efforts are urgently needed to reduce HIV and HCV contraction and transmission among individuals with OUD. Mobile health educational interventions may offer a time- and cost-effective approach for addressing these risks.

show abstract

Section: Methodssupporting

confidence: 82%

A novel mHealth application for improving HIV and Hepatitis C knowledge in individuals with opioid use disorder: A pilot study

Ochalek

Heil

Higgins

et al. 2018

Drug and Alcohol Dependence

Self Cite

View full text Add to dashboard Cite

show abstract

“…Interim buprenorphine maintenance treatment has been shown to dramatically decrease the use of illicit opioids among those awaiting initiation of comprehensive MAT programs and substantially increase retention in long-term treatment. 20,30,31 With the recent expansion of the limits on buprenorphine prescriptions to 275 patients per provider (part of the waiver required under the Drug Addiction Treatment Act [DATA] of 2000 to provide outpatient buprenorphine treatment, also known as a DATA waiver), this may be an increasingly promising option for hospital discharge.…”

Section: Toward Evidence-based Inpatient Managementmentioning

confidence: 99%

Expanding Treatment Opportunities for Hospitalized Patients with Opioid Use Disorders

Winetsky

Weinrieb

Perrone

2017

Journal of Hospital Medicine

View full text Add to dashboard Cite

The prevalence of opioid use disorders (OUDs) is rising across the United States. Patients with OUDs are often hospitalized for medical conditions other than addiction, such as infection, injury, or pregnancy. These hospital admissions provide an opportunity for healthcare providers to initiate opioid agonist therapy with methadone or buprenorphine. Randomized trials have demonstrated the superior effectiveness of this treatment strategy, but its adoption by hospital providers has been slow. A number of barriers have impeded its implementation, including misperceptions about the regulation of opioid prescribing, limited resources for the transition to community- based treatment, and a lack of familiarity among clinicians about the appropriate initiation and dose adjustment of these opioid agonists for maintenance therapy. We discuss changes in policy and practice to expand opportunities to engage patients with OUDs in opioid agonist treatment during their inpatient hospitalizations.

show abstract

“…The current U.S. opioid addiction epidemic, which is having a devastating effect on U.S. population health, is an excellent example of this phenomenon (Compton et al, 2015; Sigmon et al, 2016; Volkow and Collins, 2017). Such unhealthy personal behavior patterns are estimated to be the largest contributor to premature deaths in the U.S. annually (~40%), with cigarette smoking alone being responsible for greater than 480,000 deaths/year in the U.S and 5 million globally (Higgins, 2015; Schroeder, 2016; Woolf and Aron, 2013).…”

Section: Unhealthy Behavior Patterns and Risk For Chronic Disease mentioning

confidence: 99%

Editorial for the special issue on behavior change, health, and health disparities 2017

Higgins

2017

Preventive Medicine

Self Cite

View full text Add to dashboard Cite

This Special Issue of Preventive Medicine (PM) is the 4th in a series on behavior change, health, and health disparities, a topic of critical importance to improving U.S. population health. The U.S. ranks near the bottom on measures of population health relative to other industrialized countries despite spending orders of magnitude more on health care than any other nation. Population health experts agree that the area of personal behavior, or lifestyle, such as substance abuse, physical inactivity/obesity, and non-adherence with medical regimens is the single largest contributor to this situation. These unhealthy behavior patterns disproportionately impact economically disadvantaged populations and other vulnerable populations and represent a major contributor to health disparities. Thus, behavior change represents an essential step in improving population health generally and curtailing health disparities more specifically. While perhaps more severe in the U.S., other industrialized countries are facing similar challenges with personal behavior patterns, adverse health impacts, and health disparities. Thus the topics discussed in this series have implications well beyond the U.S. In this 4th Special Issue we address (a) the potential health impacts of liberalizing laws on recreational marijuana use; (b) the ongoing challenge of tobacco use in vulnerable populations; and (b) the importance of weight management and physical activity in caring for vulnerable medical populations. Across each of these topics we include contributions from accomplished policymakers and scientists to acquaint readers with recent accomplishments and remaining knowledge gaps and challenges in these important topic areas.

show abstract

Interim Buprenorphine vs. Waiting List for Opioid Dependence

Cited by 67 publications

References 5 publications

A novel mHealth application for improving HIV and Hepatitis C knowledge in individuals with opioid use disorder: A pilot study

A novel mHealth application for improving HIV and Hepatitis C knowledge in individuals with opioid use disorder: A pilot study

Expanding Treatment Opportunities for Hospitalized Patients with Opioid Use Disorders

Editorial for the special issue on behavior change, health, and health disparities 2017

Contact Info

Product

Resources

About